ReviewJournal of nanobiotechnology2025

Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases.

Juan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.